Healthcare / Medical Care FacilitiesHKSE
$1.08
+0.02 (+1.89%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $202.3M · quality 71.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.3B
P/E
13.5x
↓EV/EBITDA
3.6x
↓ROE
5.7%
↑Gross Margin
31.0%
↓Debt/Equity
0.24
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+4.0%
FCF CAGR
+40.1%
FCF margin
10.4%
FCF / Net income
2.02x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.95B · net income $100.4M · FCF $202.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.95B | $1.95B | $1.91B | $1.92B | $1.73B |
| Net Income | $100.4M | $100.4M | $-135.2M | $62.0M | $-21.9M |
| EBITDA | $378.6M | $378.6M | $278.9M | $363.4M | $232.5M |
| EPS | 0.08 | 0.08 | -0.11 | 0.05 | -0.02 |
| Gross Margin | 31.0% | 31.0% | 27.6% | 32.2% | 25.9% |
| Operating Margin | 6.9% | 6.9% | 2.8% | 6.2% | -0.9% |
| Net Margin | 5.2% | 5.2% | -7.1% | 3.2% | -1.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.24 | 0.24 | 0.25 | 0.20 | 0.24 |
| Current Ratio | 1.43 | 1.43 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $202.3M | $202.3M | $123.6M | $245.3M | $73.6M |
| Returns | |||||
| ROE | 5.7% | 5.7% | -7.7% | 3.4% | -1.2% |
| Valuation | |||||
| P/E | 13.50 | 13.50 | — | 67.81 | — |
| EV/EBITDA | 3.65 | 3.65 | 8.41 | 11.16 | 25.80 |
| P/B | 0.73 | 0.73 | 1.33 | 2.28 | 3.32 |
| Growth & Yield | |||||
| Revenue Growth | 1.8% | 1.8% | -0.6% | 11.1% | — |
| EPS Growth | 176.0% | 176.0% | -321.9% | 379.1% | — |
| Dividend Yield | 1.8% | 1.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
4.8%
EPS terminal req.
$0.10
Spread vs growth
171.2%
5Y implied EPS CAGR
6.8%
EPS terminal req.
$0.12
Spread vs growth
169.2%
10Y implied EPS CAGR
8.4%
EPS terminal req.
$0.19
Spread vs growth
167.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-33.9%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.11 → 0.08
Residual
-35.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.